Superworth

Journey Medical EPS DERM

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Last 12 months, to Jun 30, 2026
−$0.23
Latest quarter, Q2 FY26
−$0.01
Fiscal year 2025
−$0.48

Journey Medical's earnings per share was −$0.23 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.01.

Earnings per share over time

Open the interactive chart, with overlays and comparisons

Fiscal year by fiscal year

Fiscal yearEPSChange
FY2025−$0.48n/a
FY2024−$0.75n/a
FY2023−$0.34n/a
FY2022−$1.68n/a
FY2021−$4.08n/a
FY2020n/an/a

Each fiscal year is the twelve months to its fourth quarter.

Quarter by quarter

QuarterEndedEPSOn a year earlierLast 12 months
Q2 FY26−$0.01n/a−$0.23
Q1 FY26−$0.08n/a−$0.38
Q4 FY25−$0.05−171%−$0.48
Q3 FY25−$0.09n/a−$0.36
Q2 FY25−$0.16n/a−$0.39
Q1 FY25−$0.18n/a−$0.40
Q4 FY24$0.07n/a−$0.75
Q3 FY24−$0.12−115%−$0.93
Q2 FY24−$0.17n/a−$0.01
Q1 FY24−$0.53n/a−$0.30
Q4 FY23−$0.11n/a−$0.34
Q3 FY23$0.80n/a−$0.83

Against its peers

Companies in Drug Manufacturers - General nearest Journey Medical's size, closest first, today.

CompanyEPS, 12 monthsGrowth
DERMJourney Medical−$0.23
NATRNatures Sunshine Products$1.01+36% a year
LFVNLifevantage$0.40−46% a year
SPROSpero Therapeutics$0.11
ATNMActinium Pharmaceuticals$0.36
ARVNArvinas$0.16
PBYIPuma Biotechnology$0.52−47% a year
IRWDIronwood Pharmaceuticals$0.77
ZVRAZevra Therapeutics$0.93
CRMDCorMedix$2.13+184% a year
COLLCollegium Pharmaceutical$1.24+19% a year
Peer median$0.65

What the EPS figure tells you

Net income divided by diluted shares. The denominator of PE.

One-off charges and gains swing it. The TTM view smooths a single odd quarter.

More on Journey Medical

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.